Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Merck Sharp & Dohme LLC
National Cancer Institute (NCI)
Pheon Therapeutics
Merck Sharp & Dohme LLC
Tagworks Pharmaceuticals BV
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Iovance Biotherapeutics, Inc.
St. Jude Children's Research Hospital
University of Alabama at Birmingham
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Pfizer
Pfizer
Turning Point Therapeutics, Inc.
Taiho Oncology, Inc.
NRG Oncology
Alterome Therapeutics, Inc.
Hôpital NOVO
Boston Scientific Corporation
Peking University People's Hospital
SillaJen, Inc.
Eastern Cooperative Oncology Group
Case Comprehensive Cancer Center
University Hospital, Toulouse
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Roswell Park Cancer Institute
ToLymph Inc.
Emory University
Nuvectis Pharma, Inc.
George Washington University
AstraZeneca
Replimune Inc.
AstraZeneca
Avenzo Therapeutics, Inc.
Shanghai Pulmonary Hospital, Shanghai, China
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Emory University
Stanford University
Auricula Biosciences Inc.
iOMEDICO AG
DualityBio Inc.
NATCO Pharma Ltd.